Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford GBD (Global Burden of Disease) Group was established in July 2018 at the University of Oxford's Big Data Institute to work in partnership with the Institute for Health Metrics and Evaluation (IHME) at the University of Washington to conduct strategic research in epidemiology and public health.

Our flagship project, GRAM (Global Research on Antimicrobial Resistance), is supported by the UK Department of Health, the Bill and Melinda Gates Foundation and the Wellcome Trust to provide rigorous quantitative evidence of antimicrobial resistance to increase global awareness, boost surveillance efforts and promote the rational use of antimicrobials worldwide. This evidence will assist policy-makers in achieving future reductions in morbidity, mortality and other impacts associated with antimicrobial resistance.

The GRAM Project is led by IHME Director Chris Murray, who co-authored the seminal Global Burden of Disease Study in 1996. Prof Murray serves as GRAM's scientific director, with Prof Simon Hay of IHME and Prof Christiane Dolecek of the University of Oxford contributing scientific expertise towards specific project outputs. Within Oxford, the BDI team is led by Research Group Leader Dr Catrin Moore, with Prof Dolecek, Prof Benn Sartorius, and Prof Ben Cooper providing expertise from the Centre for Tropical Medicine and Global Health. Profs Mohsen Naghavi and Andy Stergachis are senior investigators contributing expertise and directing disease burden estimation at IHME and the University of Washington, respectively. Learn more about our research.